Genetic and environmental analysis of diseases with major economic impact in Israeli Holsteins.

Incidences of ketosis, metritis, mastitis, and retained placenta were studied in Israeli Holstein cows calving between 2008 and 2017. These diseases were selected based on their economic impact. Ketosis, metritis, and retained placenta were scored dichotomously. Mastitis was scored as absent, a single occurrence during the lactation, or more than 1 occurrence. Ketosis and metritis were recorded during the first 21 d after calving, retained placenta during the first 5 d after calving, and mastitis up to 305 d in milk. The effects of herd-year-season, calving age, month of calving, gestation length, and occurrence of dystocia were included in the first-parity analysis models. All effects were significant for metritis and retained placenta. For ketosis, all effects were significant, except for gestation length. For mastitis, only the effects of herd-year-season and calving age were significant. Variance components were computed by the multitrait animal model. The 4 diseases were analyzed jointly based on first-parity records, and each disease was analyzed separately for parities 1 to 3 with the different parities considered separate traits. The 4 disease traits in first parity were also analyzed jointly with the 6 major traits included in the Israeli breeding index: milk, fat, and protein production; somatic cell score; female fertility; and longevity. Heritability was highest for metritis and lowest for mastitis, but all heritabilities were <0.07, similar to previous studies. For all 4 diseases, genetic correlations among the first 3 parities were >0.65, and all residual correlations were <0.07. Selection of herd-years assumed to have more accurate recording of mastitis did not result in higher heritability estimates. Genetic correlations between the disease traits and milk, fat, and protein production were economically unfavorable, while correlations between the disease traits and somatic cell score, female fertility, and longevity were economically favorable. Expected genetic changes in the disease traits after 10 yr of selection with the current Israeli breeding index were all <1%, except for ketosis, which was predicted to increase by 1.5%. Inclusion of these traits in a proposed index with the disease traits constituting 7% of the index would result in only marginal improvements for the disease traits and adversely affect genetic gain for fat and protein production. Thus, inclusion of these traits in the breeding index cannot be justified economically.

Impacto econômico da retenção de placenta em vacas leiteiras / Economic impact of retained placenta in dairy cows

Aproximadamente 75% das doenças em vacas leiteiras acontecem no primeiro mês após o parto e esses problemas têm sua origem associada ao sistema imune e ao consumo de alimentos duas a três semanas antes do parto. Doenças relacionadas ao trato reprodutivo como, por exemplo, retenção de placenta pode afetar a eficiência reprodutiva assim como a produção de leite. Os efeitos das doenças nos processos fisiológicos dos animais se transformam em impactos econômicos passíveis de serem mensurados. Objetivou-se avaliar o impacto econômico da retenção de placenta em um rebanho composto de 900 vacas em lactação. O diagnóstico de retenção de placenta foi definido como presença da placenta 24 horas após o parto. Foi utilizado um banco de dados no estudo, do qual foram extraídas as seguintes informações: ano de parição, época de parição, ordem de lactação, presença da placenta 24 horas após o parto, e número de doses de sêmen por gestação. Para cálculo do impacto econômico foram considerados os custos diretos (tratamento, mão de obra, redução da produção de leite e descarte de leite durante o período de tratamento) e indiretos (aumento do período de serviço, aumento do número de doses de sêmen e aumento do risco de descarte). Os valores médios relacionados aos custos foram obtidos junto ao veterinário responsável pela propriedade com referência ao ano de 2009 para que os cálculos fossem realizados. O custo total por ocorrência de retenção de placenta em vacas primíparas no período de chuva e seca foi de US$51,8 e em vacas multíparas foi de US$70,6 e US$87,9 nas épocas de seca e de chuvas, respectivamente. A retenção de placenta apresentou custo para a propriedade no período avaliado de US$8.878,0 ou 19.666 litros de leite. A retenção de placenta apresentou impacto econômico importante na propriedade leiteira nas condições avaliadas.(AU)

Approximately 75% of diseases in dairy cows occur in the first month after parturition and these problems have their origin associated with the immune system and food consumption two to three weeks before parturition. Diseases related to the reproductive tract, such as retained placenta, can affect reproductive efficiency as well as milk production. The effects of diseases on the physiological processes of animals become economic impacts that can be measured. The objective of this study was to evaluate the economic impact of retained placenta on a herd of 900 lactating cows. The diagnosis of placental retention was defined as presence of the placenta 24 hours postpartum. A database was used in the study, from which the following information was extracted: placenta presence 24 hours after calving, year of calving, calving season, and number of semen doses per gestation. In order to calculate the economic impact, the direct costs (treatment, labor, reduction of milk production and milk discharge during the treatment period) and indirect costs (increase in the service period, increase in the number of semen doses and increase of the risk of disposal). The average values related to the costs were obtained from the veterinarian responsible for the property with reference to the year 2009 for the calculations to be carried out. The total cost per occurrence of placenta retention in primiparous cows in the rainy and dry season was US$51.8 and in multiparous cows was US$70.6 and US$87.9 in times of drought and rain, respectively. Retention of placenta presented a cost for the property in the evaluated period of US$8,878.0 or 19,666 liters of milk. Retention of placenta presented a significant economic impact on milk production under the conditions evaluated.(AU)

A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.

INTRODUCTION: A retained placenta is diagnosed when the placenta is not delivered following delivery of the baby. It is a major cause of postpartum haemorrhage and treated by the operative procedure of manual removal of placenta (MROP). METHODS AND ANALYSIS: The aim of this pragmatic, randomised, placebo-controlled, double-blind UK-wide trial, with an internal pilot and nested qualitative research to adjust strategies to refine delivery of the main trial, is to determine whether sublingual glyceryl trinitrate (GTN) is (or is not) clinically and cost-effective for (medical) management of retained placenta. The primary clinical outcome is need for MROP, defined as the placenta remaining undelivered 15 min poststudy treatment and/or being required within 15 min of treatment due to safety concerns. The primary safety outcome is measured blood loss between administration of treatment and transfer to the postnatal ward or other clinical area. The primary patient-sided outcome is satisfaction with treatment and a side effect profile. The primary economic outcome is net incremental costs (or cost savings) to the National Health Service of using GTN versus standard practice. Secondary outcomes are being measured over a range of clinical and economic domains. The primary outcomes will be analysed using linear models appropriate to the distribution of each outcome. Health service costs will be compared with multiple trial outcomes in a cost-consequence analysis of GTN versus standard practice. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the North-East Newcastle & North Tyneside 2 Research Ethics Committee (13/NE/0339). Dissemination plans for the trial include the Health Technology Assessment Monograph, presentation at international scientific meetings and publication in high-impact, peer-reviewed journals. TRIAL REGISTRATION NUMBER: ISCRTN88609453; Pre-results.

Demographic, institutional and obstetrical risk factors for postpartum haemorrhage mortality.

This study, initially presented at the SMFM Annual Conference in San Diego on 29 January 2009, sought to explore the risk factors for mortality from postpartum haemorrhage (PPH). A total of 138,316 cases of PPH from 1991 to 2000 were identified using the California Health Discharge Database. Data analysed included demographic information and clinical risk factors. PPH increased from 1.9% to 2.8%, while mortality rate decreased during the study period (1991-2000). Logistic regression showed that hysterectomy, hypertensive disorders, abruption, transverse caesarean delivery, and classical caesarean delivery, increased risk for PPH mortality, while manual placental extraction, episiotomy, and laceration repairs decreased risk. Two geographical regions, Inland Empire and Orange County, were associated with increased PPH mortality, despite having lower incidence of PPH. Teaching status and investor ownership of hospitals increased the risk of PPH mortality. There was no associated change in mortality based on hospital quality rating.

The costs of production diseases in dairy herds in England.

Economic losses due to common health problems in dairy cattle were investigated in 90 Friesian/Holstein herds (average size 152 cows), which calved in England during the 1992/1993 season with an average annual yield of about 6000 l per cow. By using only the direct costs of common production diseases and other health problems (mastitis, lameness, vulval discharge, treatments for oestrus-not-observed, retained foetal membranes, milk fever, twinning, calf mortality and aid at calving), the cost of ill health in a 100 cow herd with average rates of these problems (compared with target levels) was estimated at Pounds 6300 per year. The costs ranged from Pounds 1200 (average of the top 10%) to Pounds 13600 (average of the worst 10% of the herds). The main losses were due to mastitis and lameness (38 and 27% of health cost, respectively).

Bovine retained placenta: aetiology, pathogenesis and economic loss.

The literature on the effects and causes of retained placenta in the cow is reviewed. On a herd basis the condition can adversely affect milk yield and fertility, but on an individual cow basis the effects are unpredictable. The aetiology of retained placenta has been extensively studied and many causal factors have been implicated, but little is known of how many of them cause the condition. As a result its prevention and prediction is uncertain, primarily because of the lack of knowledge of the normal process of placental release. Vascular changes and uterine contractions play a role in placental release, but current opinion suggests that the primary cause of retained placenta is the retention of the feto-maternal union. Release only occurs after a process of maturation, which involves hormonal and structural changes. The factors which are thought to influence these changes, and thus cause the condition, are discussed.